(Q28182651)

2

0 references

M Hirai

3

0 references

Y Hinokio

4

0 references

Y Tanizawa

5

0 references

A Matsutani

6

0 references

J Satoh

7

0 references

Y Oka

Insulin resistance and vascular function

8

0 references

language of work or name

English

0 references

publication date

July 2003

0 references

published in

Diabetologia

0 references

volume

46

0 references

issue

7

0 references

page(s)

972-6

0 references

cites work

1 reference

12 December 2020

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

12 December 2020

Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease

1 reference

12 December 2020

Urotensin II evokes potent vasoconstriction in humans in vivo

1 reference

12 December 2020

Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey

1 reference

12 December 2020

Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p

1 reference

12 December 2020

Inhibition of insulin release by urotensin II--a study on the perfused rat pancreas

1 reference

12 December 2020

Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries

1 reference

12 December 2020

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

1 reference

12 December 2020

Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14

1 reference

12 December 2020

Is urotensin-II the new endothelin?

1 reference

12 December 2020

Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord

1 reference

12 December 2020

Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).

1 reference

12 December 2020

Pathogenesis of NIDDM. A balanced overview

1 reference

12 December 2020

Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction

1 reference

12 December 2020

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

12 December 2020